Renoprotective effects of AVE0991, a nonpeptide Mas receptor agonist, in experimental acute renal injury

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Barroso, Lívia Corrêa ^a   Silveira, Kátia Daniela ^a   Lima, Cristiano Xavier ^a   Borges, Valdinéria ^a   Bader, Michael ^b   Rachid, Milene ^a   Santos, Robson Augusto Souza ^a   Souza, Danielle Gloria ^a   Simões E Silva, Ana Cristina ^a   Teixeira, Mauro Martins ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; MYELOPEROXIDASE; N ETHYLCARBAMOYL 3 [4 (5 FORMYL 4 METHOXY 2 PHENYL 1 IMIDAZOLYLMETHYL)PHENYL] 5 ISOBUTYL 2 THIOPHENESULFONAMIDE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DRUG ACTIVITY; DRUG CLEARANCE; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; HISTOPATHOLOGY; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RENAL PROTECTION; SERUM OSMOLALITY; TREATMENT RESPONSE;

EID: 84862520175     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/808726     Document Type: Article

References (45)

1. Agrawal M., Swartz R., Acute renal failure. American Family Physician 2000 61 7 2077 2088 2-s2.0-0034175640 (Pubitemid 30225614)
2. Abuelo J. G., Normotensive ischemic acute renal failure. New England Journal of Medicine 2007 357 8 797 805 2-s2.0-34548084570
3. Chertow G. M., Burdick E., Honour M., Bonventre J. V., Bates D. W., Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. Journal of the American Society of Nephrology 2005 16 11 3365 3370 2-s2.0-33644874086 10.1681/ASN.2004090740 (Pubitemid 46179340)
4. Karkar A., Cytokines and glomerulonephritis. Saudi Journal of Kidney Diseases and Transplantation 2004 15 4 473 485 (Pubitemid 40008288)
5. Thadhani R., Pascual M., Bonventre J. V., Acute renal failure. New England Journal of Medicine 1996 334 22 1448 1460 2-s2.0-0030606570 (Pubitemid 126590563)
6. Jang H. R., Ko G. J., Wasowska B. A., Rabb H., The interaction between ischemia-reperfusion and immune responses in the kidney. Journal of Molecular Medicine 2009 87 9 859 864 2-s2.0-68949205568 10.1007/s00109-009-0491-y
7. Stroo I., Stokman G., Teske G. J. D., Raven A., Butter L. M., Florquin S., Leemans J. C., Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. International Immunology 2010 22 6 433 442 2-s2.0-77954012344 10.1093/intimm/dxq025
8. Benigni A., Cassis P., Remuzzi G., Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Molecular Medicine 2010 2 7 247 257 2-s2.0-77956896591 10.1002/emmm.201000080
9. Santos R. A. S., Ferreira A., Silva A. S. E., Co W.-V. V. G, Angiotensins. Cardiovascular Hormone Systems 2008 67 100
10. Iwai M., Horiuchi M., Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(17)-Mas receptor axis. Hypertension Research 2009 32 7 533 536 2-s2.0-67650541842 10.1038/hr.2009.74
11. Chappell M. C., Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(17)-Mas receptor axis: more than regulation of blood pressure? Hypertension 2007 50 4 596 599 2-s2.0-34548851716 10.1161/ HYPERTENSIONAHA.106.076216 (Pubitemid 47442717)
12. Ferrario C. M., ACE2: more of Ang-(17) or less Ang II? Current Opinion in Nephrology and Hypertension 2011 20 1 6 10.1097/MNH.0b013e3283406f57
13. Santos R. A. S., Ferreira A. J., Simões E. S. A. C., Recent advances in the angiotensin-converting enzyme 2-angiotensin(17)-Mas axis. Experimental Physiology 2008 93 5 519 527 2-s2.0-42649115768 10.1113/expphysiol.2008.042002 (Pubitemid 351595060)
14. Souza D. G., Pinho V., Soares A. C., Shimizu T., Ishii S., Teixeira M. M., Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment. British Journal of Pharmacology 2003 139 4 733 740 2-s2.0-0038340319 10.1038/sj.bjp.0705296 (Pubitemid 36819600)
15. Zoja C., Corna D., Rottoli D., Cattaneo D., Zanchi C., Tomasoni S., Abbate M., Remuzzi G., Effect of combining ACE inhibitor and statin in severe experimental nephropathy. Kidney International 2002 61 5 1635 1645 2-s2.0-0036237855 10.1046/j.1523-1755.2002.00332.x (Pubitemid 34437917)
16. Tang S. C., Leung J. C. K., Chan L. Y. Y., Eddy A. A., Lai K. N., Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy. Kidney International 2008 73 3 288 299 2-s2.0-38149125631 10.1038/sj.ki.5002674
17. Molitoris B. A., Sutton T. A., Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney International 2004 66 2 496 499 2-s2.0-3242776230 10.1111/j.1523-1755.2004.7615.x (Pubitemid 38981985)
18. Kontogiannis J., Burns K. D., Role of AT1 angiotensin II receptors in renal ischemic injury. American Journal of Physiology 1998 274 1, part 2 F79 F90 2-s2.0-0031605321
19. da Silveira K. D., Bosco K. S. P., Diniz L. R. L., Carmona A. K., Cassali G. D., Bruna-Romero O., de Sousa L. P., Teixeira M. M., Santos R. A. S., Simões E. S. A. C., Vieira M. A. R., ACE2-angiotensin-(17)-Mas axis in renal ischaemia/reperfusion injury in rats. Clinical Science 2010 119 9 385 394 2-s2.0-77956370495 10.1042/CS20090554
20. Pinheiro S. V. B., Ferreira A. J., Kitten G. T., da Silveira K. D., da Silva D. A., Santos S. H. S., Gava E., Castro C. H., Magalhes J. A., da Mota R. K., Botelho-Santos G. A., Bader M., Alenina N., Santos R. A. S., Simoes E. S. A. C., Genetic deletion of the angiotensin-(17) receptor Mas leads to glomerular hyperfiltration and microalbuminuria. Kidney International 2009 75 11 1184 1193 2-s2.0-67349127050 10.1038/ki.2009.61
21. Esteban V., Heringer-Walther S., Sterner-Kock A., de Bruin R., van den Engel S., Wang Y., Mezzano S., Egido J., Schultheiss H. P., Ruiz-Ortega M., Walther T., Angiotensin-(17) and the G protein-coupled receptor Mas are key players in renal inflammation. PLoS ONE 2009 4 4 2-s2.0-65549108738 10.1371/journal.pone.0005406 e5406
22. Silveira K. D., Coelho F. M., Vieira A. T., Sachs D., Barroso L. C., Costa V. V., Bretas T. L. B., Bader M., The administration of the agonist of angiotensin-(17), AVE0991, improved inflammation and proteinuria in experimental nephrotic syndrome. 25 Proceedings of the 15th Congress of the International Pediatric Nephrology Association 2010 New York, NY, USA Pediatric Nephrology 1779 2004
23. Mackie F. E., Campbell D. J., Meyer T. W., Intrarenal angiotensin and bradykinin peptide levels in the remnant kidney model of renal insufficiency. Kidney International 2001 59 4 1458 1465 2-s2.0-0035066891 10.1046/j.1523-1755. 2001.0590041458.x (Pubitemid 32281235)
24. Benter I. F., Yousif M. H. M., Cojocel C., Al-Maghrebi M., Diz D. I., Angiotensin-(17) prevents diabetes-induced cardiovascular dysfunction. American Journal of PhysiologyHeart and Circulatory Physiology 2007 292 1 H666 H672 2-s2.0-33846221988 10.1152/ajpheart.00372.2006 (Pubitemid 46105230)
25. Liu C. X., Hu Q., Wang Y., Zhang W., Ma Z. Y., Feng J. B., Wang R., Wang X. P., Dong B., Gao F., Zhang M. X., Zhang Y., Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition. Molecular Medicine 2011 17 1-2 59 69 10.2119/molmed.2010.00111
26. Zhang J., Noble N. A., Border W. A., Huang Y., Infusion of angiotensin-(17) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. American Journal of PhysiologyRenal Physiology 2010 298 3 F579 F588 2-s2.0-77649125799 10.1152/ajprenal.00548.2009
27. Shiota A., Yamamoto K., Ohishi M., Tatara Y., Ohnishi M., Maekawa Y., Iwamoto Y., Takeda M., Rakugi H., Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice. Hypertension Research 2010 33 4 298 307 2-s2.0-77950466786 10.1038/hr.2009.231
28. Burns W. C., Velkoska E., Dean R., Burrell L. M., Thomas M. C., Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways. American Journal of Physiology 2010 299 3 F585 F593 2-s2.0-77956458326 10.1152/ajprenal.00538.2009
29. Bonventre J. V., Zuk A., Ischemic acute renal failure: an inflammatory disease? Kidney International 2004 66 2 480 485 2-s2.0-3242772187 10.1111/j.1523-1755.2004.7612.x (Pubitemid 38981982)
30. Kelly K. J., Williams W. W., Colvin R. B., Meehan S. M., Springer T. A., Gutiérrez-Ramos J. C., Bonventre J. V., Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. Journal of Clinical Investigation 1996 97 4 1056 1063 2-s2.0-0030067639 (Pubitemid 26070586)
31. Lee H. T., Park S. W., Kim M., D'Agati V. D., Acute kidney injury after hepatic ischemia and reperfusion injury in mice. Laboratory Investigation 2009 89 2 196 208 2-s2.0-59049105433 10.1038/labinvest.2008.124
32. de Greef K. E., Ysebaert D. K., Dauwe S., Persy V., Vercauteren S. R., Mey D., de Broe M. E., Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney International 2001 60 4 1415 1427 2-s2.0-0034796763 10.1046/j.1523-1755.2001.0600041415.x (Pubitemid 32960035)
33. Molls R. R., Savransky V., Liu M., Bevans S., Mehta T., Tuder R. M., King L. S., Rabb H., Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. American Journal of Physiology 2006 290 5 F1187 F1193 2-s2.0-33646541373 10.1152/ajprenal.00342.2005 (Pubitemid 43724919)
34. Souza D. G., Cara D. C., Cassali G. D., Coutinho S. F., Silveira M. R., Andrade S. P., Poole S. P., Teixeira M. M., Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat. British Journal of Pharmacology 2000 131 8 1800 1808 2-s2.0-0034528005 (Pubitemid 32056448)
35. Pompermayer K., Souza D. G., Lara G. G., Silveira K. D., Cassali G. D., Andrade A. A., Bonjardim C. A., Passaglio K. T., Assreuy J., Cunha F. Q., Vieira M. A. R., Teixeira M. M., The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia/reperfusion injury in rats. Kidney International 2005 67 5 1785 1796 2-s2.0-20244364826 10.1111/j.1523-1755.2005. 00276.x (Pubitemid 40577713)
36. Pulskens W. P., Teske G. J., Butter L. M., Roelofs J. J., van der Poll T., Florquin S., Leemans J. C., Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS ONE 2008 3 10 2-s2.0-56349089258 10.1371/journal.pone.0003596 e3596
37. Roelofs J. J., Rouschop K. M. A., Leemans J. C., Claessen N., de Boer A. M., Frederiks W. M., Lijnen H. R., Weening J. J., Florquin S., Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. Journal of the American Society of Nephrology 2006 17 1 131 140 2-s2.0-33645458568 10.1681/ASN.2005010089
38. Wu H., Chen G., Wyburn K. R., Yin J., Bertolino P., Eris J. M., Alexander S. I., Sharland A. F., Chadban S. J., TLR4 activation mediates kidney ischemia/reperfusion injury. Journal of Clinical Investigation 2007 117 10 2847 2859 2-s2.0-34948835806 10.1172/JCI31008 (Pubitemid 47529615)
39. Li L., Sung S. S. J., Lobo P. I., Brown M. G., Gregg R. K., Engelhard V. H., Okusa M. D., NKT cell activation mediates neutrophil IFN- γ production and renal eschemia-reperfusion injury. Journal of Immunology 2007 178 9 5899 5911 2-s2.0-34247554222 (Pubitemid 46674387)
40. Al-Maghrebi M., Benter I. F., Diz D. I., Endogenous angiotensin-(17) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats. Pharmacological Research 2009 59 4 263 268 2-s2.0-61349136870 10.1016/j.phrs.2008.12.008
41. Schrier R. W., Wang W., Poole B., Mitra A., Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. Journal of Clinical Investigation 2004 114 1 5 14 2-s2.0-3242811296 10.1172/JCI200422353 (Pubitemid 39071636)
42. Zhou L., Yao X., Chen Y., Dexamethasone pretreatment attenuates lung and kidney injury in cholestatic rats induced by hepatic ischemia/reperfusion. Inflammation. In press 10.1007/s10753-011-9318-4
43. Grigoryev D. N., Liu M., Hassoun H. T., Cheadle C., Barnes K. C., Rabb H., The local and systemic inflammatory transcriptome after acute kidney injury. Journal of the American Society of Nephrology 2008 19 3 547 558 2-s2.0-40449094520 10.1681/ASN.2007040469 (Pubitemid 351355398)
44. Souza D. G., Coutinho S. F., Silveira M. R., Cara D. C., Teixeira M. M., Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats. European Journal of Pharmacology 2000 403 1-2 121 128 2-s2.0-0034283793 10.1016/S0014-2999(00)00574-4
45. Silveira K. D., Coelho F. M., Vieira A. T., Sachs D., Barroso L. C., Costa V. V., Bretas T. L. B., Bader M., de Sousa L. P., da Silva T. A., dos Santos R. A. S., E Silva A. C. S., Teixeira M. M., Anti-inflammatory effects of the Activation of the angiotensin-(17) receptor, mas, in experimental models of arthritis. Journal of Immunology 2010 185 9 5569 5576 2-s2.0-78149482692 10.4049/jimmunol.1000314